- 8
- 1 885
Lumos Diagnostics
เข้าร่วมเมื่อ 13 ก.พ. 2024
Lumos Diagnostics specializes in rapid and complete point-of-care diagnostic test technology to help
healthcare professionals more accurately diagnose and manage medical conditions. Lumos offers
customized assay development and manufacturing services for point-of-care tests and proprietary digital
reader platforms. Lumos also directly develops, manufactures, and commercializes novel Lumos-branded
point-of-care tests that target infectious and inflammatory diseases.
For more information visit lumosdiagnostics.com
healthcare professionals more accurately diagnose and manage medical conditions. Lumos offers
customized assay development and manufacturing services for point-of-care tests and proprietary digital
reader platforms. Lumos also directly develops, manufactures, and commercializes novel Lumos-branded
point-of-care tests that target infectious and inflammatory diseases.
For more information visit lumosdiagnostics.com
Lumos October Investor Update
In this video, Lumos CEO and Managing Director, Doug Ward and Vice President of Medical Affairs, Annie Bell discuss Lumos' partnership with the U.S. Biomedical Advanced Research and Development Authority (BARDA) to support the coming FebriDx® CLIA waiver study and US FDA application.
มุมมอง: 13
วีดีโอ
Lumos August Investor Update
มุมมอง 1122 หลายเดือนก่อน
Lumos CEO, Doug Ward, Chief Financial Officer, Barrie Lambert, and Senior VP Commercial Operations, Paul Kase present an overview of the Company‘s outstanding FY24 results and recent progress.
Paul Kase, Lumos SVP, Commercial Operations, discusses Henry Schein agreements | JULY 2024
มุมมอง 1633 หลายเดือนก่อน
In this video, Lumos’ SVP, Commercial Operations, Paul Kase discusses how Lumos is working in partnership with the Henry Schein Group to access key global markets, and the imminent availability of FebriDx® to Australian healthcare practitioners as Australia enters its peak flu season.
FebriDx Live Action Training Video (US)
มุมมอง 2395 หลายเดือนก่อน
FebriDx Live Action Training Video (US)
FebriDx Live Action Training Video (Outside US)
มุมมอง 555 หลายเดือนก่อน
FebriDx Live Action Training Video (Outside US)
Lumos Q3 FY24 | Interview with Doug Ward | April 2024
มุมมอง 8125 หลายเดือนก่อน
Lumos Diagnostics CEO, Doug Ward, discusses the Company's recent quarterly activity statement and cash flow report and the notable achievements and milestones from Q3 FY24.
Lumos H1 FY24 Financial Results Presentation | 29 February 2024
มุมมอง 497 หลายเดือนก่อน
Lumos H1 FY24 Financial Results Presentation | 29 February 2024
🌷 "Promosm"